We report a successfully treated case of severe thallium intoxication that required 95 days of assisted ventilation and 224 days of hospitalization.
Since its discovery, thallium has been associated with toxicity. Sir William Crookes, its discoverer, and his assistant Lamy both suffered from its toxic effects and the latter did some toxicological studies on dogs, ducks, and hens (1) . After the turn of the century, the simple salts of thallium were used in various therapeutic roles but this was stopped by 1912 because of the toxic side effects (2) . Notwithstanding this, the use of thallium salts, especially thallium(I) acetate, was restarted as a treatment for Trichophyton infection (3) until again withdrawn around 1940. The general lack of smell, color, and taste of the simple salts, and the insidious onset and protean nature of the symptoms of toxicity, make thallium salts an excellent choice for the poisoner (4). The literature contains many conflicting accounts of the pharmacokinetics of thallium (5) (6) (7) (8) , particularly with regard to tissue distribution and rates of elimination. These inconsistencies may result from differences in dose, species, and individual variation; it also may reflect the fact that analytical methods and equipment have only recently been able to measure thallium reliably at toxic and physiological concentrations (9) (10) (11) with an acceptable degree of accuracy and precision.
The aim of this paper is to present some reliable data from a successfully treated case of thallium poisoning.
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Determinations Figure   1 shows the changes in thallium concentrations in urine, serum, and whole blood after the patient's admission and treatment; Figure   2 shows the ratio of urine thallium to creatinine. We used a logarithmic scale for the concentrations of thallium to accommodate the large range of values.
All estimates show random fluctuations on the declining trend.
We attempted to fit mixtures of exponential models to the available data, using a Gauss-Newton optimization method with various different weighting functions. None of the curves could be expressed in terms of a combination of exponential models. Only two relatively short periods of data conformed to any simple model; these covered part of the early collection period of both serum and blood, a single exponential function providing an approximate fit ( Table  1 ). The half-lifetime for both the serum and blood values between days 8 and 40 was about four days; after this, the rate of decrease slowed considerably and data could no longer be approximated.
For no period could the urine thallium or ratio of urine thallium to creatinine excretion curve be fitted to a descriptive pharmacokinetics curve. 
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